Top Markets
Coin of the day
Pharma Mar, S.A. Pharma Mar, S.A.

Pharma Mar, S.A.

PHM
Kedudukan dalam Saham #7111
Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and... Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and headquartered in Madrid, Spain, is dedicated to the research, development, production, and global sale of marine-derived bioactive compounds. Its primary focus is oncology, with operations spanning Spain, Italy, Germany, Ireland, the wider European Union, the United States, and other international markets. The company's activities are organized into three key segments: Oncology, Diagnostics, and RNA interference. Among its developed and commercialized treatments are Yondelis, prescribed for soft tissue sarcomas and ovarian cancer; Aplidin, targeting multiple myeloma; and Zepzelca, used for patients with small cell lung cancer. Furthermore, Pharma Mar is advancing PM14, currently in Phase II clinical trials for various solid tumors. Beyond pharmaceuticals, the company manufactures and markets diagnostic kits and is involved in creating therapeutic drugs designed to reduce or silence gene expression.
Harga Saham
$99.34
Modal Pasaran
$1.72B
Perubahan (1 hari)
0.18%
Perubahan (1 tahun)
2.70%
Negara
ES
Perdagangan Pharma Mar, S.A. (PHM)

Kategori

Sejarah pecahan saham untuk Pharma Mar, S.A. (PHM)
Saham Pharma Mar, S.A. (simbol: PHM) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 28, 2026.
Satu saham PHM yang dibeli sebelum Aug 28, 2026 kini bersamaan dengan 0 saham PHM.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH